Veracyte, Inc.
DE ˙ DB ˙ US92337F1075
40,53 € ↓ -2,45 (-5,70%)
2026-06-05
DEL PRIS
SecurityDE:12V / Veracyte, Inc.
InstitutionVictory Capital Management Inc
Latest Disclosed Ownership25,386 shares
Latest Disclosed Value $ 817,683
Victory Capital Management Inc reports 6.69% increase in ownership of 12V / Veracyte, Inc.

On May 15, 2026 - Victory Capital Management Inc filed a 13F-HR form disclosing ownership of 25,386 shares of Veracyte, Inc. (DE:12V) valued at $675,268 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 23,794 shares of Veracyte, Inc.. This represents a change in shares of 6.69% during the quarter. The current value of the position is $1,028,895 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VERACYTE COM 92337F107 25,386 1,592 6.69 818 -18.38 0.0004
2026-02-13 2025-12-31 13F VERACYTE COM 92337F107 23,794 -12,596 -34.61 1,002 -19.86 0.0006
2025-11-12 2025-09-30 13F VERACYTE COM 92337F107 36,390 -88,191 -70.79 1,249 -62.90 0.0007
2025-08-13 2025-06-30 13F VERACYTE COM 92337F107 124,581 26,795 27.40 3,367 16.14 0.0022
2025-05-02 2025-03-31 13F VERACYTE COM 92337F107 97,786 41,248 72.96 2,899 29.54 0.0030
2025-02-06 2024-12-31 13F VERACYTE COM 92337F107 56,538 -28,905 -33.83 2,239 -23.04 0.0022
2024-11-05 2024-09-30 13F VERACYTE COM 92337F107 85,443 -2,112 -2.41 2,908 53.29 0.0028
2024-08-05 2024-06-30 13F VERACYTE COM 92337F107 87,555 15,647 21.76 1,897 19.08 0.0019
2024-05-03 2024-03-31 13F VERACYTE COM 92337F107 71,908 649 0.91 1,593 -18.72 0.0016
2024-02-05 2023-12-31 13F VERACYTE COM 92337F107 71,259 14,219 24.93 1,960 53.97 0.0021
2023-11-06 2023-09-30 13F VERACYTE COM 92337F107 57,040 137 0.24 1,274 -12.15 0.0015
2023-07-27 2023-06-30 13F VERACYTE COM 92337F107 56,903 39,336 223.92 1,449 270.59 0.0016
2023-05-02 2023-03-31 13F VERACYTE COM 92337F107 17,567 17,567 392 0.0004
2023-04-25 2022-12-31 13F/A-3 VERACYTE COM 92337F107 0 -43,929 -100.00 0 -100.00
2023-03-10 2022-12-31 13F/A-2 VERACYTE COM 92337F107 0 -43,929 0
2023-02-10 2022-12-31 13F/A-1 VERACYTE COM 92337F107 0 -43,929 0
2023-02-09 2022-12-31 13F VERACYTE COM 92337F107 0 -43,929 0
2022-11-02 2022-09-30 13F VERACYTE COM 92337F107 43,929 -49,247 -52.85 729 -60.68 0.0009
2022-08-01 2022-06-30 13F VERACYTE COM 92337F107 93,176 38,329 69.88 1,854 65.09 0.0021
2022-05-04 2022-03-31 13F VERACYTE COM 92337F107 54,847 86 0.16 1,123 -50.22 0.0011
2022-02-07 2021-12-31 13F VERACYTE COM 92337F107 54,761 -8,732 -13.75 2,256 -23.50 0.0021
2021-11-02 2021-09-30 13F VERACYTE COM 92337F107 63,493 -3,508 -5.24 2,949 10.08 0.0029
2021-08-03 2021-06-30 13F VERACYTE COM 92337F107 67,001 -1,076 -1.58 2,679 -26.78 0.0026
2021-05-04 2021-03-31 13F VERACYTE COM 92337F107 68,077 -4,793 -6.58 3,659 2.61 0.0037
2021-02-01 2020-12-31 13F VERACYTE COM 92337F107 72,870 -6,774 -8.51 3,566 37.79 0.0040
2020-11-09 2020-09-30 13F Veracyte COM 92337F107 79,644 -25,545 -24.28 2,588 -4.99 0.0033
2020-08-07 2020-06-30 13F VERACYTE COM 92337F107 105,189 -65 -0.06 2,724 6.45 0.0037
2020-05-12 2020-03-31 13F/A-1 VERACYTE COM 92337F107 105,254 1,286 1.24 2,559 -11.85 0.0043
2020-05-04 2020-03-31 13F VERACYTE COM 92337F107 105,254 1,286 2,559 2,800.5655
2020-02-06 2019-12-31 13F/A-1 VERACYTE COM 92337F107 103,968 8,415 8.81 2,903 26.60 0.0035
2020-02-04 2019-12-31 13F VERACYTE COM 92337F107 102,209 6,656 2,683 3,216.0870
2019-11-12 2019-09-30 13F VERACYTE COM 92337F107 95,553 95,553 2,293 0.0030
2019-05-03 2019-03-31 13F VERACYTE COM 92337F107 0 -221,200 -100.00 0 -100.00
2019-05-02 2018-12-31 13F/A-1 VERACYTE COM 92337F107 221,200 -8,800 -3.83 2,783 26.67 0.0070
2019-02-05 2018-12-31 13F VERACYTE COM 92337F107 221,200 -8,800 2,783
2018-11-01 2018-09-30 13F VERACYTE COM 92337F107 230,000 230,000 2,197 0.0045
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.